{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:48:43Z","timestamp":1780084123069,"version":"3.54.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12032-020-01352-2","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T11:02:49Z","timestamp":1584010969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study"],"prefix":"10.1007","volume":"37","author":[{"given":"Giulia","family":"Lassandro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Giusto","family":"Picchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovangiuseppe","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Ierardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lassandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"1352_CR1","unstructured":"IARC. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer; (2013)"},{"issue":"12","key":"1352_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of world- wide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"1","key":"1352_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/SLA.0b013e31818eec29","volume":"249","author":"WY Lau","year":"2009","unstructured":"Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249(1):20\u20135.","journal-title":"Ann Surg"},{"key":"1352_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiology.180.1.2052672","volume":"180","author":"SD Davis","year":"1991","unstructured":"Davis SD, et al. CT Evaluation for pulmonary metastases in patients with extra-thoracic malignancy. Radiology. 1991;180:1\u201312.","journal-title":"Radiology"},{"key":"1352_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiology.216.3.r00se24698","volume":"216","author":"S Katyal","year":"2000","unstructured":"Katyal S, Oliver JH, Peterson MS, et al. Extrahepatic metastases of hepatocellular carcinoma1. Radiology. 2000;216:698\u2013703. https:\/\/doi.org\/10.1148\/radiology.216.3.r00se24698.","journal-title":"Radiology"},{"key":"1352_CR6","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/j.1440-1746.2005.03919.x","volume":"20","author":"M Natsuizaka","year":"2005","unstructured":"Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20:1781\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1352_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1067\/mtc.2003.18","volume":"125","author":"LJ Herrera","year":"2003","unstructured":"Herrera LJ, Fernando HC, Perry H, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. Thorac Cardiovasc Surg. 2003;125:929\u201337.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"3","key":"1352_CR8","first-page":"237","volume":"7","author":"WY Lau","year":"2008","unstructured":"Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobil Pancr Dis Int. 2008;7(3):237\u201357.","journal-title":"Hepatobil Pancr Dis Int"},{"issue":"3","key":"1352_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1479-666X(05)80043-5","volume":"3","author":"EC Lai","year":"2005","unstructured":"Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3(3):210\u20135.","journal-title":"Surgeon"},{"key":"1352_CR10","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ejrad.2013.04.025","volume":"82","author":"J Ding","year":"2013","unstructured":"Ding J, Jing X, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma. Eur J Radiol. 2013;82:1379\u201384.","journal-title":"Eur J Radiol"},{"key":"1352_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jvir.2011.02.030","volume":"22","author":"T Hiraki","year":"2011","unstructured":"Hiraki T. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan. J Vasc Interv Radiol. 2011;22:741\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"1352_CR12","first-page":"251","volume":"44","author":"T Okusaka","year":"1997","unstructured":"Okusaka T, Okada S, Ishii H, et al. Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. Hepatogastroenterology. 1997;44:251\u20137.","journal-title":"Hepatogastroenterology"},{"key":"1352_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/02656736.2016.1237681","volume":"33","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang K, Lin SM, et al. Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperth. 2016;33:237\u201346.","journal-title":"Int J Hyperth"},{"issue":"3","key":"1352_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5761\/atcs.ra.18-00229","volume":"25","author":"F Park-Yun Cheung","year":"2019","unstructured":"Park-Yun Cheung F, et al. The past, present and future of pulmonary metastasectomy: a review article. Ann Thorac Cardiovasc Surg. 2019;25(3):129\u201341.","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"3","key":"1352_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00270-012-0500-3","volume":"36","author":"A Gillams","year":"2013","unstructured":"Gillams A, Khan Z, Osborn P, Lees W. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Interv Radiol. 2013;36(3):724\u201330.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"11","key":"1352_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jvir.2010.06.023","volume":"21","author":"JD Jaskolka","year":"2010","unstructured":"Jaskolka JD, Kachura JR, Hwang DM, et al. Pathologic assessment of radiofrequency ablation of pulmonary metastases. J Vasc Interv Radiol. 2010;21(11):1689\u201396.","journal-title":"J Vasc Interv Radiol"},{"key":"1352_CR17","first-page":"59","volume":"34","author":"Mu Luwen","year":"2017","unstructured":"Luwen Mu, Sun L, et al. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results. Int J Hyperth. 2017;34:59\u201367.","journal-title":"Int J Hyperth"},{"key":"1352_CR18","doi-asserted-by":"crossref","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Seminars in Liver Disease, Vol. 30, n 1 (2010)","DOI":"10.1055\/s-0030-1247132"},{"issue":"4","key":"1352_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/rg.324105181","volume":"32","author":"F Abtin","year":"2012","unstructured":"Abtin F, et al. Radiofrequency ablation of lung tumors: imaging features of the post-ablation zone. Radiographics. 2012;32(4):947\u201369.","journal-title":"Radiographics"},{"key":"1352_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3109\/02656736.2012.736669","volume":"28","author":"X Li","year":"2012","unstructured":"Li X, Wang J, Li W, et al. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. Int J Hyperth. 2012;28:721\u20138.","journal-title":"Int J Hyperth"},{"key":"1352_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1148\/radiol.2016151807","volume":"282","author":"T Pan","year":"2017","unstructured":"Pan T, Xie QK, Lv N, et al. Percutaneous CT-guided radiofrequency ablation for lymph node oligometastases from hepatocellular carcinoma: a propensity score-matching analysis. Radiology. 2017;282:259\u201370.","journal-title":"Radiology"},{"key":"1352_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria, a 10-year update. Radiology. 2014;273:241\u201360.","journal-title":"Radiology"},{"key":"1352_CR23","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199\u2013S202.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"1352_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejrad.2007.07.007","volume":"67","author":"K Yan","year":"2008","unstructured":"Yan K, Chen MH, Yang W, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67(2):336\u201347.","journal-title":"Eur J Radiol"},{"issue":"2","key":"1352_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1148\/radiol.2402050807","volume":"240","author":"T Ba\u00e8re","year":"2006","unstructured":"Ba\u00e8re T, Palussi\u00e8re J, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587\u201396.","journal-title":"Radiology"},{"issue":"4","key":"1352_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.diii.2012.02.001","volume":"93","author":"F Cornelis","year":"2012","unstructured":"Cornelis F, et al. Radiologically-guided thermal ablation of renal tumours. Diagn Interv Imaging. 2012;93(4):246\u201361.","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"1352_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0033-1342955","volume":"30","author":"ES Alexander","year":"2013","unstructured":"Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Interv Radiol. 2013;30(2):141\u201350.","journal-title":"Semin Interv Radiol"},{"key":"1352_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re T, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26:987\u201391.","journal-title":"Ann Oncol"},{"issue":"1","key":"1352_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5009\/gnl.2013.7.1.1","volume":"7","author":"Y Minami","year":"2013","unstructured":"Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver. 2013;7(1):1\u20136.","journal-title":"Gut Liver"},{"issue":"1","key":"1352_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner A, et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61\u201374.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"1352_CR31","doi-asserted-by":"publisher","first-page":"e0124434","DOI":"10.1371\/journal.pone.0124434","volume":"10","author":"HS Dong","year":"2015","unstructured":"Dong HS, et al. Different survival of barcelona clinic liver cancer stage c hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PLoS ONE. 2015;10(4):e0124434.","journal-title":"PLoS ONE"},{"issue":"3","key":"1352_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bcpt.12365","volume":"116","author":"Y Li","year":"2015","unstructured":"Li Y, et al. The adverse effects of Sorafenib in patients with advanced cancers. Basic Clin Pharmacol Toxicol. 2015;116(3):216\u201321.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1352_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","volume":"10","author":"Y Je","year":"2009","unstructured":"Je Y, Schutz FA, et al. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors Sunitinib and Sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncol. 2009;10:967\u201374.","journal-title":"Lancet Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-020-01352-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:45:37Z","timestamp":1615509937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-020-01352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1007\/s12032-020-01352-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that we have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"25"}}